Samjo Capital’s Ginkgo Bioworks DNA Stock Holding History

Samjo Capital’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$27.1K	Buy	+375	New	+$30K	0.01%	48

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Samjo Capital's DNA Position: Q3 2023 in Review

Samjo Capital opened a new position in Ginkgo Bioworks (DNA) in Q3 2023: 375 shares worth $27.1K. The stake represents 0.01% of the portfolio and ranks #48 among its holdings.

348 funds tracked by Wall St. Rank hold DNA as of Q3 2023.

Samjo Capital held 375 shares of Ginkgo Bioworks worth $27.1K as of Q3 2023.
Ginkgo Bioworks was a new Samjo Capital position in Q3 2023.
Ginkgo Bioworks made up 0.01% of Samjo Capital's portfolio in Q3 2023, its #48 holding.
348 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2023.

Based on Samjo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.